Mercator Medical SA
F:MM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mercator Medical SA
F:MM2
|
PL |
|
AI Cross Inc
TSE:4476
|
JP |
|
T
|
Tokai Carbon Korea Co Ltd
KOSDAQ:064760
|
KR |
|
IMAC Holdings Inc
OTC:BACK
|
US |
|
I
|
IMCD NV
F:INX
|
NL |
|
Esports Mogul Ltd
ASX:ESH
|
AU |
|
Guotai Junan Securities Co Ltd
F:153A
|
CN |
|
A
|
AEE Gold AG
DUS:AEE1
|
DE |
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
Noodles & Co
NASDAQ:NDLS
|
US |
|
Masco Corp
NYSE:MAS
|
US |
|
Beijing Tongrentang Co Ltd
SSE:600085
|
CN |
|
F
|
Fiske PLC
LSE:FKE
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MM2's stock price target?
Not Available
MM2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Mercator Medical SA?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 4 years is 36%.
What is the Gross Profit forecast for Mercator Medical SA?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 6 years is -5%.
What is the Pre-Tax Income forecast for Mercator Medical SA?
Projected CAGR
103%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 4 years is 103%.
What is the Net Income forecast for Mercator Medical SA?
Projected CAGR
115%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 4 years is 115%.
